By Judith Wenshuk, peptide research writer
Quick Answer: Melanotan-1 is more selective for pigmentation research, with less appetite-related activity, while Melanotan-2 has broader receptor activity covering both pigmentation and appetite regulation research. The choice comes down to whether your research interest is narrowly focused on pigmentation or extends into appetite research as well.
Both compounds work through the same melanocortin receptor family, available through research peptide suppliers in Canada, but they differ meaningfully in selectivity and research scope.
Key Differences
- Selectivity: Melanotan-1 is more targeted toward pigmentation specifically; Melanotan-2 has broader receptor activity
- Appetite effects: Melanotan-2 is studied for appetite-regulation effects that Melanotan-1 shows less of
- Regulatory history: Melanotan-1’s underlying compound (afamelanotide) has FDA designation for a specific medical use, giving it a somewhat more established research history
Which One Fits Your Research Focus
If your research interest is pigmentation specifically, Melanotan-1’s greater selectivity makes it the more targeted choice. If your interest extends into appetite-regulation research as well, Melanotan-2’s broader receptor activity covers more ground in a single compound.
Frequently Asked Questions
Is one stronger than the other? Not stronger — different in scope. Melanotan-2 affects a broader range of receptor activity, not a more potent version of the same effect.
Are both available in Canada? Yes — both Melanotan-1 and Melanotan-2 are available through research peptide suppliers in Canada.
Leave a Reply